Solid lipid nanoparticles (SLNs) are nanocarriers developed as substitute colloidal drug
delivery systems parallel to liposomes, lipid emulsions, polymeric nanoparticles, and so …

This work briefly reviews up-to-date developments in solid lipid nanoparticles (SLNs) as
effective nanocolloidal system for drug delivery. It summarizes SLNs in terms of their …

Chemical and enzymatic barriers in the gastrointestinal (GI) tract hamper the oral delivery of
many labile drugs. The GI epithelium also contributes to poor permeability for numerous …

Recent trends in nanoparticles-based oral therapy have led to a proliferation of studies to
enhance solubility, permeability and chemical stability of many drugs. One of the significant …

Natural products represent valuable chemical scaffolds for drug development. A recent
success story in this context was artemisinin, which is not only active against malaria but …

Antimicrobial resistance is one of the biggest threats to global health as current antibiotics
are becoming useless against resistant infectious pathogens. Consequently, new …

Nanoparticles have shown overall beneficial effects in drug administration. Specifically, solid
lipid nanoparticles (SLN) have emerged as an alternative to polymer-based systems …

The use of natural compounds in medicine for the treatment of diseases started since
ancient days. Though many natural compounds exhibit potent pharmacological activity, their …

As an emerging novel drug carrier, nanoparticles provide a promising way for effective
treatment of parasitic diseases by overcoming the shortcomings of low bioavailability, poor …

Background Lifestyle issues contribute to the development of obesity, type 2 diabetes, and
cardiovascular disease. Together with appropriate diet and exercise, nutraceuticals may …